indanidine has been researched along with inositol 1,4,5-trisphosphate in 1 studies
| Studies (indanidine) | Trials (indanidine) | Recent Studies (post-2010) (indanidine) | Studies (inositol 1,4,5-trisphosphate) | Trials (inositol 1,4,5-trisphosphate) | Recent Studies (post-2010) (inositol 1,4,5-trisphosphate) |
|---|---|---|---|---|---|
| 26 | 0 | 1 | 6,600 | 1 | 589 |
| Protein | Taxonomy | indanidine (IC50) | inositol 1,4,5-trisphosphate (IC50) |
|---|---|---|---|
| Inositol-trisphosphate 3-kinase A | Rattus norvegicus (Norway rat) | 4.45 | |
| Inositol 1,4,5-trisphosphate receptor type 2 | Homo sapiens (human) | 0.03 | |
| Inositol 1,4,5-trisphosphate receptor type 3 | Homo sapiens (human) | 0.03 | |
| Inositol 1,4,5-trisphosphate receptor type 1 | Homo sapiens (human) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biguad, M; Julou-Schaeffer, G; Parratt, JR; Stoclet, JC | 1 |
1 other study(ies) available for indanidine and inositol 1,4,5-trisphosphate
| Article | Year |
|---|---|
Endotoxin-induced impairment of vascular smooth muscle contractions elicited by different mechanisms.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Caffeine; Calcimycin; Calcium; Clonidine; Endothelium, Vascular; Endotoxins; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitrendipine; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred Strains; Sarcoplasmic Reticulum | 1990 |